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Available online 13 July 2016b3% of Americans have ideal cardiovascular health (CVH). The primary care encounter provides a setting in
which to conduct patient-provider discussions of CVH. We implemented a CVH risk assessment, visualization,
and decision-making tool that automatically populates with electronic health record (EHR) data during the en-
counter in order to encourage patient-centered CVH discussions among at-risk, yet under-treated, populations.
We quantiﬁed ﬁve of the seven CVH behaviors and factors that were available in The Ohio State University
Wexner Medical Center's EHR at baseline (May–July 2013) and compared values to those ascertained at one-
year (May–July 2014) among intervention (n= 109) and control (n= 42) patients. The CVH of women in the
intervention clinic improved relative to the metrics of body mass index (16% to 21% ideal) and diabetes (62%
to 68% ideal), but not for smoking, total cholesterol, or blood pressure.Meanwhile, the CVH of women in the con-
trol clinic either held constant or worsened slightly as measured using those same metrics. Providers need easy-
to-use tools at the point-of-care to help patients improve CVH.We demonstrated that the EHR could deliver such
a tool using an existing AmericanHeart Association framework, andwe noted small improvements in CVH in our
patient population. Future work is needed to assess how to best harness the potential of such tools in order to
have the greatest impact on the CVH of a larger patient population.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Poor cardiovascular health (CVH) is associated with an increased
risk for cardiovascular (Foraker et al., 2016; Folsom et al., 2011;
Rasmussen-Torvik et al., 2013; Kulshreshtha et al., 2013) and other
chronic diseases (Lloyd-Jones, 2014). CVH is amenable to change via
prevention efforts (Lloyd-Jones, 2014; Bambs and Reis, 2011; Foraker
et al., 2012). Population-level approaches to reduce tobacco use andmerican College of Cardiology;
support; CVH, cardiovascular
stimation equation; OSUWMC,
deviation; SPHERE, stroke pre-
llege of Public Health, 1841Neil
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. This is an open access article underpromote healthy dietary choices (Eyre et al., 2004) are needed to
achieve the American Heart Association's (AHA's) goal of “improving
the CVH of all Americans 20% by 2020” (Lloyd-Jones et al., 2010). Pre-
vention discussions at the point-of-care and early CVH interventions
in the primary care setting may enhance and reinforce population-
level strategies to improve CVH for all Americans (Peiris et al., 2015).
The increasing need for high-quality, patient-centered documenta-
tion at the point-of-care places time constraints on primary care pro-
viders, thus limiting behavior modiﬁcation counseling during a patient
encounter (Haire-Joshu and Klein, 2011; Huang et al., 2004). Evidence
suggests that patient-centeredness decreases as providers increase at-
tention to an electronic health record (EHR) (Street et al., 2014). In
fact, primary care providers spend almost as much time documenting
the encounter as they do in direct patient care (Ammenwerth and
Spötl, 2009). Further, CVH data are often located on various screens
throughout the EHR, limiting the ability of care providers to synthesize
and reason upon such data, particularly in time-constrained practice
settings. Compounding this problem, many providers lack training in
delivering prevention messages and supporting behavior change
(Kushner, 2010; Gunther et al., 2012). In a similar manner, few currentthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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as an alternative to shared decision-making (Mantwill et al., 2015;
O'Malley et al., 2015; Chrimes et al., 2014). As a result of these barriers,
few providers discuss physical activity or other lifestyle changes with
patients nor do patients receive adequate information support to enable
or promote such healthy behaviors (Eakin et al., 2005).
Clinical decision support (CDS) within EHR systems helps providers
with decision-making tasks about individual patients at the point-of-
care (Berner, 2006), and modiﬁes provider behavior by recommending
speciﬁc actions or reminding providers of clinical care guidelines
(Rothman et al., 2012), prompts smoking cessation counseling and
referrals (Shariﬁ et al., 2014), facilitates goal-setting among pre-
diabetics (Chrimes et al., 2014), lowers cholesterol (Zamora et al.,
2013), and increases appropriate prescribing (Litvin et al., 2013).
There is growing consensus for improved patient outcomes through
implementation of EHR tools in cardiothoracic surgery (Razavi et al.,
2014), specialty clinics, and primary care (Zamora et al., 2013).
In response to the preceding challenges and opportunities, we de-
veloped and evaluated a novel, easy-to-use, EHR-based CVH assessment
tool for use in primary care that automatically populates with EHR data
and renders an interactive visual display of a patient's CVH score
(Foraker et al., 2014). We hypothesized that the CVH of patients with
access to our CVH tool would improve over a one-year period, while
the CVH of patients without access to the tool would stay the same or
worsen.
2. Material and methods
As we have described previously (Foraker et al., 2014), the stroke
prevention in healthcare delivery environments (SPHERE) tool was de-
veloped and implemented in the outpatient EHR of a general internal
medicine clinic at The Ohio State University Wexner Medical Center
(OSUWMC) (Foraker et al., 2014). Brieﬂy, the SPHERE tool (Supplemen-
tary Figure) was designed to increase patient-provider communication
around prevention. The SPHERE tool launches within the EHR during a
patient encounter, and is viewable by both patient and provider. The
provider uses the interactive features of the tool (slider bars and but-
tons) to show how changes in each CVH component can impact their
overall CVH. Providers in the intervention clinic were not incentivized
to use the tool; details on its use are presented in a separate publication
(Foraker et al., 2015).
Our eligible patient population included women who were 65 years
of age or older at the time of the baseline encounter. Control clinic pa-
tients were seen in a different outpatient clinic in the OSUWMC system,
and received usual care with regard to prevention discussions. The
study, with a waiver of informed consent, was approved by The Ohio
State University's Institutional Review Board (approval number
2013H0083).
Baseline demographic and CVH data for the eligible patient popula-
tion at both clinics were obtained from the EHR for the time period of
May 1, 2013 through July 31, 2013. The SPHERE tool was accessible to
providers in the intervention clinic beginning October 6, 2013. Follow-
up CVH data were queried one-year later for encounters occurring be-
tweenMay 1, 2014 and July 31, 2014.We conducted a group-level anal-
ysis on the subset of women seen in the intervention clinic (n = 109)
and women seen in the control clinic (n = 42) who had an encounter
during both time periods. We also report on the CVH of all eligible pa-
tients seen during baseline and/or follow-up periods. Baseline data indi-
cated that 160 eligible patients were seen in the intervention clinic, and
62 eligible patients were seen in the control clinic. Follow-up data col-
lection yielded 168 eligible intervention patients and 96 eligible control
patients.
Baseline and follow-up data included the demographic variables of
age and race (white, black, other). We used the most recent data
(collected within the past 12 months) to characterize smoking status,
body mass index (BMI), total cholesterol, blood pressure, and fastingglucose/hemoglobin A1c. Two other components of CVH, physical activ-
ity and diet, were infrequently entered as unstructured data in clinic
notes, and were not computationally actionable as free text. Therefore,
we excluded these two variables from the current study report.
We assigned patients to ideal, intermediate, and poor categories of
the AHA's CVH metric as shown in Table 1, based on values associated
with each of the biometric components, with the exception of fasting
glucose/hemoglobin A1c (American Diabetes Association, 2012). For
fasting glucose, we categorized participants into ideal (not taking
glucose-lowering medication) and intermediate (taking glucose-
lowering medication) CVH categories due to high levels of missing
data for both fasting glucose and hemoglobin A1c laboratory values in
our EHR.
2.1. Statistical methods
Demographic factors in both control and intervention clinic were
characterized asmean (SD) for continuous variables and as proportions
for categorical variables. For each of the ﬁve CVH categories, the propor-
tion of women in each clinic in each category (e.g., ideal, intermediate,
or poor health or missing) was reported both at baseline and post-
intervention. Overall CVH score, calculated as 2 points for idea, 1 point
for intermediate, and 0 for poor on each of the ﬁve available factors
was calculated for each participant and the change in average CVH
score in aggregate (pre-post) for each clinic was estimated using a
GEE approach to account for correlations on women measured during
both periods. The main analysis comprised the subset of women who
were observed during both baseline and follow-up periods. A secondary
analysis investigated changes among all eligible women seen during
baseline and/or follow-up.
Data analysis was conducted using STATA (StataCorp). Statistical
signiﬁcance was set at 0.05.
3. Results
At baseline, the average age of the subset of patients seen in the in-
tervention clinic was 75 years, while the average agewas 72 in the con-
trol clinic (Table 2). Differences were seen at baseline by race between
the intervention (35% black) and control (21% black) clinics. The demo-
graphic data in the intervention clinic did not change appreciably be-
tween the baseline and follow-up periods in either clinic. The baseline
data of all eligiblewomen seen during the baseline and/or follow-uppe-
riods in the intervention clinic had a similar distribution of demographic
factors compared to the subset of patients at baseline. Similarly, the sub-
set of patients in the control clinic had nearly equivalent demographic
characteristics compared to all eligible women seen during the baseline
and/or follow-up periods in the control clinic (Table 2).
Amongwomen in the intervention clinicwhowere seen during both
the baseline and follow-up periods, we observed CVH improve on the
metrics of BMI (14.7 to 19.3% ideal) and diabetes (56.9 to 62.4% ideal)
from baseline to follow-up. Meanwhile, the CVH of women in the con-
trol clinic either held constant (diabetes; 83.3% ideal) or worsened
slightly (BMI; 23.8 to 19.0% ideal) from baseline to follow-up.
At baseline, a greater proportion of all eligible patients in the inter-
vention clinic (Fig. 1C) were in ideal CVH compared to those in the con-
trol clinic (Fig. 1D) for current smoking and total cholesterol. However,
eligible patients in the intervention clinic weremore likely to be in poor
CVH for BMI and blood pressure, and to be treated for diabetes, com-
pared to the control clinic. Among all eligible patients in the interven-
tion clinic, improvements were seen from baseline to follow-up for
BMI (18.1 to 20.2% ideal) and diabetes status (59.4 to 63.7% ideal).
Average overall CVH score increased by 0.024 (95% CI: −0.24 to
0.29) in the intervention clinic (p = 0.86), indicating that improve-
ments in BMI and diabeteswere somewhat offset by losses on other fac-
tors. Conversely, CVH components either held constant or worsened
among eligible patients seen in the control clinic. In the control clinic,
Table 1
Measures of CVH according to the American Heart Association (Lloyd-Jones et al., 2010), and cut points used for hemoglobin A1c (American Diabetes Association, 2012).
Poor health Intermediate health Ideal health
Smoking status Yes Former ≤12 months Never or quit N12 months
Body mass index ≥30 kg/m2 25–29.9 kg/m2 b25 kg/m2
Total cholesterol ≥240 mg/dL 200–239 mg/dL or treated to goal b200 mg/dL
Blood pressure Systolic ≥140 mm Hg or Diastolic ≥90 mm Hg Systolic 120–139 mm Hg or Diastolic 80–89 mm Hg or treated to goal Systolic b120 mm Hg
Diastolic b80 mm Hg
Fasting glucose ≥126 mg/dL 100–125 mg/dL or treated to goal b100 mg/dL
Hemoglobin A1c ≥6.5% 5.7–6.4% or treated to goal b5.7%
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0.44).
4. Discussion
In this relatively small sample of patients, we noted improvements
in CVH, which has important clinical implications for the prevention of
chronic disease (Lloyd-Jones, 2014). In particular, the SPHERE tool's
focus on improving the CVH of patients in primary care is consistent
with prevention services covered by the Affordable Care Act. These ser-
vices include blood pressure, cholesterol, and diabetes screening; diet
counseling; obesity screening and counseling; and tobacco screening
and cessation support. As a result, the use of a CDS tool with a focus
on prevention, like SPHERE, is responsive to the Stage 2 Meaningful
Use criteria for EHRs (HealthIT.gov, 2011a; HealthIT.gov, 2011b;
HealthIT.gov, 2013).
The SPHERE tool, by design, brings lifestyle factors into theworkﬂow
of patient care. As a result, the EHR becomes less of a passive data cap-
ture system as is typically the case, and instead, serves as the basis for
timely and efﬁcient shared decision-making. Shared decision-making
allows for patients' values, needs, and preferences to guide evidence-
based care (Barry and Edgman-Levitan, 2012), and our EHR systems
should help improve shared decision-making around prevention of
chronic disease (Kite et al., 2014). A Cochrane review of interventions
for improving the adoption of shared decision making concluded that
interventions targeting the provider and patient were more effective
than those targeting the provider or patient alone (Legare et al., 2010).
To that end, providers need easy-to-use tools at the point-of-care
to help patients improve CVH, as b3% of Americans described in
population-based studies are in ideal CVH according to AHA's metric
(Foraker et al., 2016; Folsom et al., 2011; Kulshreshtha et al., 2013;
Huffman et al., 2012; Bambs et al., 2011). We demonstrated that the
EHR could deliver such a tool using an existing AHA framework de-
signed to improve CVH (Lloyd-Jones et al., 2010). The success of the
tool is due to ease of use, seamless integration with clinical workﬂow,
functionality within the EHRwindow, non-intrusive design, and the au-
tomatic rendering of a CVH calculation at the point-of-care to improve
patient-provider communication around CVH (Foraker et al., 2015).
A unique strength of the study was the use of an intervention clinic
that was located in an underserved area of our community with a moreTable 2
Demographic characteristics of all eligible patients seen at baseline (May–July, 2013) and follo
Intervention clinic
Baseline
(all eligible patients)
Follow-up
(all eligible patients)
Baseline
(patient subset
N 160 168 109
Age (SD) 74.2 (6.7) 74.5 (7.0) 75.0 (6.8)
Race
White 93 (59%) 96 (57%) 64 (59%)
Black 56 (35%) 62 (37%) 38 (35%)
Other 9 (6%) 9 (5%) 6 (6%)
a Subset comprises patients seen in both baseline and follow-up periods.racially diverse patient population as compared to the control clinic
(Foraker et al., 2014). Our results add to a paucity of literature that dem-
onstrates improvements in CVH using EHR-based tools (Mann and Lin,
2012). Unlike existing research, our study was done in a primary care
setting and targeted all patients meeting age and clinic criteria, regard-
less of presence of comorbid conditions. Also distinct from other point-
of-care interventions, the SPHERE tool is designed to be platform-
independent and scalable to other patient populations and healthcare
settings, not to mention EHR platforms (Foraker et al., 2014; Kite et al.,
2014).
Limitations of this initial study stemprimarily from the limited num-
ber of observations for older women seen in two outpatient clinics at
baseline and again at one-year follow-up. Our data do not describe
howmany women initiated evidence-based treatment or who had lab-
oratory assessments ordered as a result of their primary care encounter.
In addition, diet and physical activity datawere not recorded in the EHR.
While we collected these data via the patient-facing EHR portal (56% re-
sponse rate), these datawere only collected at follow-up, not at baseline
(Foraker et al., 2014). In addition, we were unable to detect changes in
smoking behavior in the intervention clinic due to an already high prev-
alence of ideal smoking behavior in this clinic and the small sample size
included in both baseline and follow-up periods.
Our study overlapped with another clinic-level intervention
which targeted obese patients in the intervention clinic. The goal of
that study was to encourage eligible patients to talk to their provider
about their weight via an educational video. The medical assistant
was to play the video for the patient while they waited for their pro-
vider in the exam room prior to their appointment. Of the patients
eligible for that study, queried from the EHR fromMay 2012 through
April 2013, 36 were females 65 years of age and older. Since the re-
sults of that study are not available, we cannot comment on the pro-
portion of those 36 women who were shown the video while they
waited for their provider, and whether they were the same women
who were also eligible for the SPHERE study during a similar time
period.
5. Conclusions
This is the ﬁrst study to develop and implement an EHR-based
CVH visualization tool. Our study demonstrates that it is feasible tow-up (May–July 2014): OSUWMC.
Control clinic
*)
Baseline
(all eligible patients)
Follow-up
(all eligible patients)
Baseline
(patient subseta)
62 96 42
72.8 (7.5) 71.6 (6.7) 72.4 (7.4)
45 (73%) 76 (79%) 30 (71%)
12 (19%) 14 (15%) 9 (21%)
5 (8%) 6 (6%) 3 (7%)
Fig. 1.Changes in CVH from baseline (May–July 2013) to follow-up (May–July 2014) in the OSUWMC (A) intervention and (B) control clinics: patients seen in both baseline and follow-up
periods. Changes in CVH from baseline to follow-up in the (C) intervention and (D) control clinics: patients seen in baseline and/or follow-up periods.
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Fig. 1 (continued).
307R.E. Foraker et al. / Preventive Medicine Reports 4 (2016) 303–308implement patient-centered EHR-based tools at the point-of-care in the
primary care setting. Ourwork answers the call for next-generation EHR
design to facilitate patient-provider communication (Street et al., 2014).
The SPHERE study is a unique multidisciplinary collaboration aimed ataddressing the feasibility of using a system embedded in the EHR to im-
prove patient-centered care. Future work is needed to assess how to
best harness the potential of such tools in order to have the greatest im-
pact on the CVH of a patient population.
308 R.E. Foraker et al. / Preventive Medicine Reports 4 (2016) 303–308Supplementary data to this article can be found online at http://dx.
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